Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.1.5 (neuropathy target esterase)
1,070 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Metabolism of lysophosphatidylcholine (LPC), recently implicated in arrhythmogenesis, was characterized in rabbit ventricular homogenates. Activities of four enzymatic pathways were distinguishable after subcellular fractionation and DEAE-Sephacel chromatography including microsomal lysophospholipase, microsomal acyl coenzyme A/LPC acyltransferase, cytosolic lysophospholipase, and cytosolic lysophospholipase-transacylase. Microsomal lysophospholipase activity was attenuated 81% by acidosis comparable to that in ischemic myocardium (pH 6.5) and was inhibited by substrate. LPC acyltransferase was identified in the microsomal fraction based on CoA-dependent phosphatidyl choline synthesis, the positional specificity of acylation of LPC, and identical reaction velocities with both of its labeled co-substrates. LPC acyltransferase had a Vmax of 5.1 nmol/mg/min, a broad pH optimum centered at pH 7, and an apparent Km for LPC and palmitoyl-CoA of 14 microM and 7 microM. Cytosolic lysophospholipase was separated from lysophospholipase-transacylase by DEAE-Sephacel chromatography and distinguished from microsomal lysophospholipase by its broad pH activity curve, Michaelis-Menten kinetics (Vmax = 9.5 nmol/mg/min, Km = 7.5 microM), and lack of substrate inhibition. Lysophospholipase-transacylase was identified in the cytosolic fraction by CoA-independent phosphatidyl choline synthesis and purified 4885-fold from homogenate by ammonium sulfate precipitation, DEAE-Sephacel, hydroxylapatite, gel filtration, and polylysine chromatography. The partially purified enzyme had a transacylase/lysophospholipase activity ratio of 0.6, and transacylation of LPC was prominent at submicellar concentrations of substrate.
...
PMID:Lysophosphatidylcholine metabolism in the rabbit heart. Characterization of metabolic pathways and partial purification of myocardial lysophospholipase-transacylase. 708 96